328 related articles for article (PubMed ID: 23872437)
1. Muscle wasting from kidney failure-a model for catabolic conditions.
Wang XH; Mitch WE
Int J Biochem Cell Biol; 2013 Oct; 45(10):2230-8. PubMed ID: 23872437
[TBL] [Abstract][Full Text] [Related]
2. Molecular signaling pathways regulating muscle proteolysis during atrophy.
Franch HA; Price SR
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):271-5. PubMed ID: 15809529
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
4. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
[TBL] [Abstract][Full Text] [Related]
5. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
Langen RC; Gosker HR; Remels AH; Schols AM
Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy.
Bailey JL; Zheng B; Hu Z; Price SR; Mitch WE
J Am Soc Nephrol; 2006 May; 17(5):1388-94. PubMed ID: 16611720
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin.
Thomas SS; Mitch WE
Clin Exp Nephrol; 2013 Apr; 17(2):174-82. PubMed ID: 23292175
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
9. Review of muscle wasting associated with chronic kidney disease.
Workeneh BT; Mitch WE
Am J Clin Nutr; 2010 Apr; 91(4):1128S-1132S. PubMed ID: 20181807
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
Wang X; Hu Z; Hu J; Du J; Mitch WE
Endocrinology; 2006 Sep; 147(9):4160-8. PubMed ID: 16777975
[TBL] [Abstract][Full Text] [Related]
12. Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease.
Thomas SS; Dong Y; Zhang L; Mitch WE
Kidney Int; 2013 Aug; 84(2):308-16. PubMed ID: 23515050
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
14. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
15. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
16. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.
Zhang L; Wang XH; Wang H; Du J; Mitch WE
J Am Soc Nephrol; 2010 Mar; 21(3):419-27. PubMed ID: 20056750
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of muscle wasting in chronic kidney disease.
Wang XH; Mitch WE
Nat Rev Nephrol; 2014 Sep; 10(9):504-16. PubMed ID: 24981816
[TBL] [Abstract][Full Text] [Related]
18. Supplementation of ketoacids contributes to the up-regulation of the Wnt7a/Akt/p70S6K pathway and the down-regulation of apoptotic and ubiquitin-proteasome systems in the muscle of 5/6 nephrectomised rats.
Wang DT; Lu L; Shi Y; Geng ZB; Yin Y; Wang M; Wei LB
Br J Nutr; 2014 May; 111(9):1536-48. PubMed ID: 24502851
[TBL] [Abstract][Full Text] [Related]
19. TLR13 contributes to skeletal muscle atrophy by increasing insulin resistance in chronic kidney disease.
Gu L; Wang Z; Zhang Y; Zhu N; Li J; Yang M; Wang L; Rong S
Cell Prolif; 2022 Mar; 55(3):e13181. PubMed ID: 35088922
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms modulating muscle mass.
Glass DJ
Trends Mol Med; 2003 Aug; 9(8):344-50. PubMed ID: 12928036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
